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IN WOSPITAL COURSE OF PATIENTS TREATED WITH 
STENTS OR THE AUTOPERFUSION Cr.THETER FOR FAILED 
PTCA 
Jean-Jacques Goy, Jean-Christophe Stauffer, 
Pierre Vogt, Urs Kaufmann", Lukas Kappenbesgar, 
Division of Cardiology, University Hospital, 
Lausanne, Triemli Spital*, Zurich, Switzerland 
We compared the in-hospital cour6e of 46 pa- 
tients (pts) (8 worn- I and 38 men) (mean age of 
57 +/- 9 year) created either by prolonged 
inflation of the autoperfusion balloon catheter 
(ABC) or stent implantation (SE) following 
failed PTCA. The treated vessel was the LAD in 
19 pt6, the RCA in 19 pts, the CX in 7 pm and 
CABG in 1 pt. 28 pts were treated with SX and 
18 pt6 with ABC. All pts received hepnrin and 
urokinase. ARC was inflated at 6 to 10 bars for 
1007+/-920 sec. satisfactory 
ographic result (residual stenosis (RS) < 
) wa6 obtained in 15 pts. Emergency surgery 
(Es) Wa6 needed in 3 pts (17%). In 1 pt 
reocclusion (R) occurred 3 days later but was 
sucessfully recanalized. CR rise was noted in 2 
pts (l l%)and 11 pt bad Q wave infarction (MI). 
There was no death and all pts left the 
hospital 2 to 10 days after PTCA. 81 Wa6 
possible in all pt6. In this group ES was 
needed in 1 pt for LAD dissection. R occured in 
2 pts (7 5) and 2 pts died on day6 1 and 7 (7 
%). CR rise was observed in 7 pts (25 %) and Q 
wave MI in 1 pt. Residual stenosis was c 25 %  
in all pts after SI.Thus, both SI and ABC are 
useful1 to treat the majority of acute 
occlusion following PTCA. However ABC is more 
eimple, doe6 not need long term anticoagulation 
and should be used as first instance. 
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Cairo University, 
he technique 
ment 
of balloon dilatation, assess- 
of its success asd initial results in 6 
Pts with valvular tricuspid stenosis (TS) axe 
reported. T s had TS after surgical mitral 
ilth isolated TS and 3 had 
combined 
performed. 
Simultaneous RA an RV pressure 
triCU6pid valve area (TVA1 and 
valve orifice diameter fTVD1 measured from 
inflation 
when the wires were wedged in 
ulmonary artery. 
of 2.5 .z 0.3 mmHg and a mean of 
< 0.01. 
0.2 mmNb, p 
r39rlil; 
formula before and after dilatation were 
i eaaceurate e to the low gradient and 
r-espinatory ressure variation. The TVD 
increased by &e than 150%. 
The successful technique used for 
balloon dilatation of the uncommon TS and 
methods of assessing the results need hollow up 
and further confirmation. 
Immune Function and Myocardial Infarction 
Linda Casale, Kirk Lebowitz, Kevin A. Wilson, 
Mark T. Welch, Alan S. Maisel, San Diego VA 
Medical Center and University of California 
Catecholamine release dampens several 
parameters of immunity. We asked whether 
patients resenting with myocardial 
infarction (MI) had alterations in delayed 
hypersensitivity as assessed by skin testing. 
Furthermore, we hypothesized that those 
patients with the largest MIS and therefore 
the greatest sympathetic response would have 
the greatest immune dysfunction. The skin 
testing procedure consisted of pressing a 
disposable plastic applicator with 8 sterile 
test heads preloaded with seven delayed 
hypersensitivity skin tests and a glycerin 
control on the patient's forearm within 12 
hours of presentation with WI. Tests were 
read at 24 and 48 hours. At 24 hours, while 
46% of skin tests were positive (22 mm in 
duration) when the total CPK was < 500 IU 
only 9% were positive when the CPK was > 500 
IU (pc.001). The low CPK group had a sum of 
size of induration of reactive tests per 
patient of 13.5 mm at 24 hrs and 9.9 m m  at 48 
hrs, ver6us 1.8 at 24 hrs and 4 mm at 48 hrs 
for the high CPK group. Additionally, in 
patients who were anergic to all skin tests, 
the total CPK was 3741 vs 912 in those not 
anergic (pc.001). Patients who died in the 
hospital were more likely to be anergic (67% 
vs 18%). Thus there is a direct correlation 
between infarct size and alteration in 
cellular immunity. These abnormalities may 
affect subsequent morbidity and mortality. 
